ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE

ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE was reported 1508 times

ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SMALL INTESTINAL POLYPECTOMY 2 0.5000
1 OSMOLAR GAP INCREASED 15 0.1485
2 BLOOD OSMOLARITY INCREASED 11 0.0334
3 ANALGESIC DRUG LEVEL DECREASED 1 0.0227
4 PO2 INCREASED 11 0.0217
5 BORDERLINE OVARIAN TUMOUR 1 0.0149
6 CORYNEBACTERIUM TEST POSITIVE 1 0.0141
7 FIBROUS DYSPLASIA OF BONE 1 0.0135
8 ANION GAP INCREASED 17 0.0127
9 FALLOPIAN TUBE OPERATION 1 0.0125
10 WOUND DECOMPOSITION 2 0.0120
11 FOETAL HEART RATE INCREASED 1 0.0114
12 EXAGGERATED STARTLE RESPONSE 2 0.0109
13 ALCOHOL TEST FALSE POSITIVE 1 0.0106
14 AUTOIMMUNE ENCEPHALOPATHY 1 0.0099
15 PNEUMOCONIOSIS 2 0.0095
16 ADRENAL CYST 1 0.0091
17 DECORTICATE POSTURE 1 0.0089
18 ABDOMINAL REBOUND TENDERNESS 1 0.0089
19 ANALGESIC DRUG LEVEL INCREASED 14 0.0087
20 BILIRUBIN URINE PRESENT 1 0.0084
21 DECEREBRATE POSTURE 1 0.0068
22 GASTRIC CYST 1 0.0066
23 URINE AMPHETAMINE POSITIVE 2 0.0061
24 PNEUMONITIS CHEMICAL 2 0.0057
25 DRUG TITRATION ISSUE 1 0.0055
26 COLOBOMA 1 0.0053
27 EXPOSURE TO EXTREME TEMPERATURE 1 0.0052
28 CHRONIC HEPATITIS C 2 0.0051
29 ANTICHOLINERGIC SYNDROME 8 0.0050
30 DUCTUS ARTERIOSUS PREMATURE CLOSURE 2 0.0049
31 RESPIRATORY RATE DECREASED 15 0.0048
32 GENITAL DISORDER MALE 1 0.0047
33 EXPOSURE VIA INHALATION 1 0.0046
34 BLOOD ETHANOL INCREASED 1 0.0045
35 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
36 QRS AXIS ABNORMAL 3 0.0039
37 GINGIVAL EROSION 1 0.0039
38 CUTIS LAXA 1 0.0037
39 BLOOD PH INCREASED 2 0.0036
40 BLOOD OSMOLARITY DECREASED 2 0.0032
41 CARBON DIOXIDE ABNORMAL 1 0.0032
42 THIRST DECREASED 2 0.0032
43 CONDUCTIVE DEAFNESS 1 0.0031
44 CATHETER SITE BRUISE 1 0.0030
45 GASTRIC MUCOSA ERYTHEMA 1 0.0030
46 COMMINUTED FRACTURE 1 0.0030
47 PRECANCEROUS CONDITION 2 0.0030
48 CORONAVIRUS TEST POSITIVE 3 0.0029
49 ASTHMA EXERCISE INDUCED 1 0.0029
50 DISEASE RECURRENCE 136 0.0029
51 BLOOD FOLATE DECREASED 2 0.0028
52 GLOBULINS INCREASED 1 0.0027
53 CARDIOVASCULAR SYMPTOM 1 0.0026
54 RENAL HAEMANGIOMA 2 0.0025
55 BLOOD LACTIC ACID INCREASED 13 0.0025
56 COMA SCALE ABNORMAL 7 0.0024
57 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
58 BONE SCAN ABNORMAL 1 0.0024
59 SYMPTOM RECURRENCE 14 0.0023
60 ALCOHOL WITHDRAWAL SYNDROME 2 0.0023
61 BANKRUPTCY 1 0.0022
62 DIABETIC EYE DISEASE 1 0.0022
63 REACTION TO EXCIPIENT 5 0.0022
64 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
65 EAR MALFORMATION 1 0.0022
66 AURA 4 0.0021
67 PCO2 DECREASED 2 0.0021
68 ALCOHOL INTERACTION 4 0.0021
69 AMNESTIC DISORDER 1 0.0021
70 SUBCUTANEOUS EMPHYSEMA 2 0.0020
71 DRAINAGE 1 0.0020
72 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
73 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
74 METABOLIC ALKALOSIS 3 0.0019
75 FRACTURE PAIN 1 0.0019
76 AUTOSCOPY 1 0.0019
77 PERIRECTAL ABSCESS 2 0.0018
78 ENDOMETRIAL THICKENING 1 0.0018
79 BONE FRAGMENTATION 1 0.0018
80 SPLEEN DISORDER 3 0.0018
81 HEAD BANGING 1 0.0018
82 CARBON DIOXIDE DECREASED 2 0.0017
83 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
84 HEPATORENAL FAILURE 1 0.0017
85 HAEMATOCRIT ABNORMAL 2 0.0016
86 SINUS TACHYCARDIA 23 0.0016
87 BLOOD UREA DECREASED 2 0.0016
88 FOETAL HEART RATE DECREASED 1 0.0016
89 BRONCHITIS VIRAL 1 0.0015
90 CLUSTER HEADACHE 2 0.0015
91 GRAVITATIONAL OEDEMA 1 0.0014
92 PERIODONTAL DISEASE 2 0.0014
93 CONGENITAL HYDRONEPHROSIS 1 0.0014
94 TRACHEOSTOMY 2 0.0014
95 AMNIOTIC CAVITY INFECTION 1 0.0014
96 ACCOMMODATION DISORDER 1 0.0014
97 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
98 SLEEP PARALYSIS 2 0.0014
99 BLUNTED AFFECT 1 0.0014
100 ARTERIAL INJURY 1 0.0013
101 PROTHROMBIN TIME PROLONGED 8 0.0013
102 BASOPHIL COUNT INCREASED 1 0.0013
103 CHROMATOPSIA 1 0.0013
104 DIZZINESS EXERTIONAL 1 0.0013
105 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
106 FOREIGN BODY IN UROGENITAL TRACT 1 0.0013
107 FOREIGN BODY IN THROAT 4 0.0013
108 HEAT EXHAUSTION 1 0.0012
109 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
110 RESPIRATORY ALKALOSIS 2 0.0012
111 FEAR OF FALLING 1 0.0012
112 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
113 MEDICAL PROCEDURE 2 0.0012
114 CULTURE POSITIVE 1 0.0012
115 EXPOSURE VIA INGESTION 3 0.0012
116 SEIZURE LIKE PHENOMENA 2 0.0012
117 APTYALISM 1 0.0012
118 LAZINESS 2 0.0012
119 ACUTE SINUSITIS 2 0.0012
120 TACHYPHRENIA 4 0.0012
121 CYSTOCELE 1 0.0012
122 DRUG SCREEN POSITIVE 9 0.0011
123 HAEMOCHROMATOSIS 1 0.0011
124 BONE CYST 1 0.0011
125 BLOOD BICARBONATE DECREASED 2 0.0011
126 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
127 ACUTE HEPATIC FAILURE 14 0.0010
128 COVID-19 176 0.0010
129 ANORECTAL DISORDER 2 0.0010
130 REBOUND ACID HYPERSECRETION 3 0.0010
131 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
132 RENAL MASS 2 0.0010
133 TONGUE BITING 2 0.0010
134 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
135 BINGE EATING 1 0.0009
136 PLASMA CELL MYELOMA RECURRENT 3 0.0009
137 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
138 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
139 FOCAL DYSCOGNITIVE SEIZURES 1 0.0009
140 DYSLEXIA 1 0.0009
141 GAMBLING 1 0.0009
142 BLADDER OPERATION 1 0.0009
143 BILIRUBIN CONJUGATED INCREASED 2 0.0009
144 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
145 FACIAL BONES FRACTURE 3 0.0008
146 BLOOD PHOSPHORUS DECREASED 3 0.0008
147 AMPUTATION 1 0.0008
148 TACHYARRHYTHMIA 2 0.0008
149 PRE-EXISTING CONDITION IMPROVED 5 0.0008
150 HYPERPARATHYROIDISM SECONDARY 2 0.0008
151 FACE INJURY 3 0.0008
152 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
153 GLUCOSE URINE PRESENT 1 0.0008
154 AMMONIA INCREASED 4 0.0008
155 INCREASED BRONCHIAL SECRETION 2 0.0008
156 BLOOD CHLORIDE DECREASED 2 0.0008
157 DRUG TITRATION ERROR 2 0.0008
158 NASOPHARYNGITIS 140 0.0008
159 DEVICE MISUSE 1 0.0008
160 BRADYPNOEA 2 0.0007
161 LACTIC ACIDOSIS 24 0.0007
162 AGORAPHOBIA 1 0.0007
163 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
164 DRUG SCREEN FALSE POSITIVE 2 0.0007
165 BLOOD UREA INCREASED 12 0.0007
166 CARDIOVERSION 1 0.0007
167 ECHOCARDIOGRAM ABNORMAL 1 0.0007
168 HALLUCINATIONS, MIXED 3 0.0007
169 BUNDLE BRANCH BLOCK LEFT 3 0.0007
170 NECK MASS 2 0.0007
171 AUDITORY DISORDER 1 0.0007
172 BLOOD ELECTROLYTES DECREASED 1 0.0007
173 PSYCHOLOGICAL TRAUMA 6 0.0007
174 EYELID MARGIN CRUSTING 2 0.0007
175 FAT TISSUE INCREASED 1 0.0007
176 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
177 GENERALISED ANXIETY DISORDER 1 0.0007
178 ANKLE OPERATION 1 0.0007
179 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
180 ANGIOPLASTY 1 0.0007
181 AGE-RELATED MACULAR DEGENERATION 1 0.0007
182 BRONCHIAL DISORDER 1 0.0006
183 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
184 FURUNCLE 5 0.0006
185 EXPOSURE TO TOXIC AGENT 2 0.0006
186 SNEEZING 14 0.0006
187 ANOSMIA 9 0.0006
188 NASAL CONGESTION 36 0.0006
189 RHINORRHOEA 39 0.0006
190 DEMENTIA ALZHEIMER'S TYPE 1 0.0006
191 INTENTIONAL OVERDOSE 38 0.0006
192 EROSIVE OESOPHAGITIS 1 0.0006
193 CHOLECYSTITIS 7 0.0006
194 IMPAIRED GASTRIC EMPTYING 8 0.0006
195 GLIOBLASTOMA 1 0.0006
196 BLOOD PH DECREASED 1 0.0006
197 VITAMIN D DECREASED 5 0.0006
198 FIXED ERUPTION 1 0.0006
199 CHOREA 1 0.0006
200 BLOOD CHLORIDE INCREASED 1 0.0006
201 HYPOPNOEA 2 0.0006
202 FANCONI SYNDROME ACQUIRED 1 0.0006
203 FOOD INTERACTION 1 0.0006
204 NYSTAGMUS 3 0.0006
205 BREAST CYST 1 0.0006
206 CHEILITIS 3 0.0006
207 HYPERKERATOSIS 3 0.0005
208 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
209 SARS-COV-2 TEST POSITIVE 7 0.0005
210 PARANASAL SINUS DISCOMFORT 2 0.0005
211 THYROID MASS 2 0.0005
212 SINUS DISORDER 10 0.0005
213 OBSTRUCTION 2 0.0005
214 EJACULATION FAILURE 1 0.0005
215 TRIGEMINAL NEURALGIA 2 0.0005
216 CARDIAC DISCOMFORT 1 0.0005
217 FOAMING AT MOUTH 1 0.0005
218 ENURESIS 2 0.0005
219 SEASONAL ALLERGY 7 0.0005
220 END STAGE RENAL DISEASE 9 0.0005
221 TASTE DISORDER 10 0.0005
222 DIVERTICULAR PERFORATION 1 0.0005
223 DYSGEUSIA 36 0.0005
224 CHEST INJURY 1 0.0005
225 SECRETION DISCHARGE 6 0.0005
226 NASAL DRYNESS 3 0.0005
227 MYDRIASIS 6 0.0005
228 HAEMOGLOBIN ABNORMAL 3 0.0005
229 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
230 ABSCESS INTESTINAL 1 0.0005
231 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
232 OCULAR ICTERUS 2 0.0005
233 CHAPPED LIPS 2 0.0005
234 ENDOMETRIAL CANCER 1 0.0005
235 DYSMENORRHOEA 6 0.0005
236 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
237 POST-TRAUMATIC STRESS DISORDER 3 0.0004
238 FEAR OF DEATH 1 0.0004
239 REBOUND EFFECT 5 0.0004
240 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
241 ECCHYMOSIS 3 0.0004
242 EAR DISORDER 2 0.0004
243 ONYCHOCLASIS 3 0.0004
244 HAIR GROWTH ABNORMAL 3 0.0004
245 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
246 LARGE INTESTINE PERFORATION 3 0.0004
247 BLOOD POTASSIUM INCREASED 7 0.0004
248 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
249 HYPOVOLAEMIC SHOCK 2 0.0004
250 TONGUE DISORDER 3 0.0004
251 SUICIDE ATTEMPT 25 0.0004
252 HORMONE LEVEL ABNORMAL 2 0.0004
253 HAEMATOLOGICAL INFECTION 1 0.0004
254 DERMAL CYST 1 0.0004
255 CEREBRAL DISORDER 3 0.0004
256 PROTEIN URINE PRESENT 2 0.0004
257 OROPHARYNGEAL PAIN 37 0.0004
258 ECONOMIC PROBLEM 6 0.0004
259 DERMATOMYOSITIS 1 0.0004
260 ENDODONTIC PROCEDURE 1 0.0004
261 EXCORIATION 1 0.0004
262 DRY THROAT 4 0.0004
263 APPENDICITIS PERFORATED 1 0.0004
264 AORTIC ARTERIOSCLEROSIS 1 0.0004
265 MULTIPLE ALLERGIES 3 0.0004
266 ORAL CANDIDIASIS 5 0.0004
267 INFLUENZA 42 0.0004
268 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
269 COUGH 105 0.0004
270 BREAST SWELLING 1 0.0004
271 DECREASED ACTIVITY 4 0.0004
272 GAMBLING DISORDER 1 0.0004
273 SINUS CONGESTION 5 0.0004
274 EAR CONGESTION 1 0.0004
275 ABDOMINAL RIGIDITY 1 0.0004
276 ANORGASMIA 1 0.0004
277 BLOOD POTASSIUM DECREASED 11 0.0004
278 ESCHERICHIA INFECTION 3 0.0004
279 ASTHENOPIA 2 0.0004
280 AUTISM SPECTRUM DISORDER 2 0.0004
281 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
282 DENTAL CARIES 4 0.0004
283 AGEUSIA 9 0.0004
284 EOSINOPHIL COUNT INCREASED 3 0.0004
285 PANIC ATTACK 13 0.0004
286 CHRONIC KIDNEY DISEASE 27 0.0004
287 PRODUCT ADMINISTRATION ERROR 7 0.0003
288 HEAD DISCOMFORT 6 0.0003
289 CREPITATIONS 1 0.0003
290 LOSS OF CONSCIOUSNESS 43 0.0003
291 ATYPICAL PNEUMONIA 1 0.0003
292 THROAT IRRITATION 15 0.0003
293 ACNE CYSTIC 1 0.0003
294 PLATELET COUNT ABNORMAL 2 0.0003
295 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
296 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
297 CHEST X-RAY ABNORMAL 1 0.0003
298 TOXICITY TO VARIOUS AGENTS 55 0.0003
299 ECTOPIC PREGNANCY 1 0.0003
300 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
301 BRAIN DEATH 1 0.0003
302 ILEUS 4 0.0003
303 HEPATIC ENCEPHALOPATHY 3 0.0003
304 BLOOD BLISTER 1 0.0003
305 BLOOD CREATININE DECREASED 1 0.0003
306 BRAIN FOG 5 0.0003
307 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
308 RESPIRATORY TRACT CONGESTION 5 0.0003
309 SLEEP APNOEA SYNDROME 6 0.0003
310 SCREAMING 2 0.0003
311 METABOLIC ACIDOSIS 10 0.0003
312 ATELECTASIS 3 0.0003
313 DIZZINESS POSTURAL 3 0.0003
314 APPETITE DISORDER 2 0.0003
315 EXPIRED DEVICE USED 1 0.0003
316 COAGULOPATHY 5 0.0003
317 VAGINAL DISCHARGE 3 0.0003
318 PRODUCTIVE COUGH 14 0.0003
319 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
320 EUPHORIC MOOD 3 0.0003
321 INITIAL INSOMNIA 3 0.0003
322 BRONCHOPNEUMONIA 1 0.0003
323 RESPIRATION ABNORMAL 2 0.0003
324 BLOOD CREATININE ABNORMAL 1 0.0003
325 EYE DISCHARGE 3 0.0003
326 MENTAL STATUS CHANGES 8 0.0003
327 AORTIC STENOSIS 1 0.0003
328 HANGOVER 1 0.0003
329 DEPRESSIVE SYMPTOM 1 0.0003
330 HEART DISEASE CONGENITAL 1 0.0003
331 THERMAL BURN 2 0.0003
332 GLOSSITIS 1 0.0003
333 PARALYSIS 4 0.0003
334 PARAESTHESIA ORAL 4 0.0003
335 MENSTRUATION DELAYED 3 0.0003
336 SKIN LACERATION 3 0.0003
337 BLOOD CREATININE INCREASED 18 0.0003
338 FAECES SOFT 2 0.0003
339 OESOPHAGITIS 3 0.0003
340 FOOD INTOLERANCE 1 0.0003
341 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
342 URINARY INCONTINENCE 8 0.0003
343 FEELING DRUNK 2 0.0003
344 RESPIRATORY TRACT INFECTION 7 0.0003
345 MALNUTRITION 3 0.0003
346 GENERAL SYMPTOM 2 0.0003
347 BREAST TENDERNESS 2 0.0003
348 HEPATIC NECROSIS 1 0.0003
349 ACIDOSIS 2 0.0003
350 INSURANCE ISSUE 4 0.0003
351 GINGIVAL DISORDER 1 0.0003
352 NIGHTMARE 9 0.0003
353 APNOEA 2 0.0003
354 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
355 EPIGASTRIC DISCOMFORT 1 0.0003
356 BLOOD PRESSURE DECREASED 17 0.0003
357 INSOMNIA 68 0.0003
358 AFFECTIVE DISORDER 2 0.0003
359 BLOOD IRON DECREASED 3 0.0003
360 NASAL DISCOMFORT 2 0.0003
361 BLOOD ALBUMIN DECREASED 2 0.0003
362 MYOCLONUS 3 0.0003
363 AZOTAEMIA 1 0.0003
364 MIOSIS 2 0.0002
365 FUNGAL SKIN INFECTION 1 0.0002
366 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
367 ACCIDENTAL OVERDOSE 9 0.0002
368 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
369 DECUBITUS ULCER 2 0.0002
370 HYPERSOMNIA 7 0.0002
371 BRONCHITIS 18 0.0002
372 HAIR DISORDER 2 0.0002
373 SPINAL COMPRESSION FRACTURE 2 0.0002
374 LIVER FUNCTION TEST ABNORMAL 7 0.0002
375 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
376 UTERINE PERFORATION 2 0.0002
377 ABSCESS LIMB 1 0.0002
378 HEPATIC PAIN 1 0.0002
379 ALCOHOLISM 1 0.0002
380 SKIN ULCER 6 0.0002
381 PARANOIA 4 0.0002
382 BLOOD MAGNESIUM DECREASED 2 0.0002
383 HYSTERECTOMY 2 0.0002
384 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
385 URINE OUTPUT DECREASED 2 0.0002
386 DIVERTICULUM INTESTINAL 1 0.0002
387 IMMUNE SYSTEM DISORDER 3 0.0002
388 TOOTH INFECTION 3 0.0002
389 ABDOMINAL ABSCESS 1 0.0002
390 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
391 EAR INFECTION 6 0.0002
392 FEELING ABNORMAL 54 0.0002
393 GLOSSODYNIA 5 0.0002
394 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
395 ANAL INCONTINENCE 2 0.0002
396 DYSPHONIA 13 0.0002
397 PRODUCT TASTE ABNORMAL 3 0.0002
398 DRUG INTERACTION 35 0.0002
399 MIGRAINE 21 0.0002
400 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
401 DYSPAREUNIA 1 0.0002
402 INTENTIONAL PRODUCT MISUSE 19 0.0002
403 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
404 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
405 HUNGER 3 0.0002
406 APHONIA 3 0.0002
407 THINKING ABNORMAL 4 0.0002
408 SINUSITIS 22 0.0002
409 MASS 3 0.0002
410 MIDDLE INSOMNIA 4 0.0002
411 BLISTER 12 0.0002
412 FOOT FRACTURE 4 0.0002
413 SPUTUM DISCOLOURED 2 0.0002
414 CARDIAC TAMPONADE 1 0.0002
415 GESTATIONAL DIABETES 1 0.0002
416 SUBDURAL HAEMATOMA 3 0.0002
417 IMPAIRED QUALITY OF LIFE 3 0.0002
418 LETHARGY 12 0.0002
419 LOCALISED INFECTION 5 0.0002
420 MENTAL IMPAIRMENT 5 0.0002
421 EAR PAIN 4 0.0002
422 MENORRHAGIA 4 0.0002
423 APPLICATION SITE BURN 1 0.0002
424 DIABETIC NEUROPATHY 1 0.0002
425 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
426 INABILITY TO AFFORD MEDICATION 2 0.0002
427 ABDOMINAL TENDERNESS 1 0.0002
428 BLOOD PRESSURE ABNORMAL 4 0.0002
429 HYPOTONIA 2 0.0002
430 OVERDOSE 43 0.0002
431 SEIZURE 23 0.0002
432 HYPOAESTHESIA ORAL 3 0.0002
433 HYPOXIA 7 0.0002
434 SOMNOLENCE 40 0.0002
435 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
436 EXTRA DOSE ADMINISTERED 8 0.0002
437 DRY MOUTH 16 0.0002
438 CHILLS 23 0.0002
439 SLUGGISHNESS 2 0.0002
440 NEUTROPHIL COUNT INCREASED 2 0.0002
441 MUSCULOSKELETAL CHEST PAIN 3 0.0002
442 TEMPERATURE INTOLERANCE 2 0.0002
443 ANKLE FRACTURE 3 0.0002
444 UNRESPONSIVE TO STIMULI 5 0.0002
445 POOR VENOUS ACCESS 2 0.0002
446 FAILURE TO THRIVE 1 0.0002
447 POLLAKIURIA 8 0.0002
448 SEDATION 5 0.0002
449 SPEECH DISORDER 10 0.0002
450 DYSURIA 7 0.0002
451 HEAD INJURY 6 0.0002
452 HALLUCINATION, AUDITORY 3 0.0002
453 RENAL PAIN 2 0.0002
454 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
455 BODY HEIGHT DECREASED 2 0.0002
456 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
457 HALLUCINATION 14 0.0002
458 ANAL ABSCESS 1 0.0002
459 WHEEZING 11 0.0002
460 BRUXISM 1 0.0002
461 BLOOD BILIRUBIN INCREASED 5 0.0002
462 THROAT TIGHTNESS 5 0.0002
463 FAECES DISCOLOURED 4 0.0002
464 ILLNESS 19 0.0002
465 VAGINAL HAEMORRHAGE 8 0.0002
466 BIPOLAR DISORDER 2 0.0002
467 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
468 INFLUENZA LIKE ILLNESS 15 0.0002
469 GASTROINTESTINAL PAIN 2 0.0002
470 PHOTOSENSITIVITY REACTION 3 0.0002
471 TOOTH FRACTURE 2 0.0002
472 CHOKING SENSATION 1 0.0002
473 DRUG LEVEL INCREASED 3 0.0002
474 VENTRICULAR FIBRILLATION 2 0.0002
475 TRANSAMINASES INCREASED 4 0.0002
476 HEART RATE ABNORMAL 1 0.0002
477 ANXIETY 51 0.0002
478 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
479 VOMITING 84 0.0002
480 SKIN INFECTION 2 0.0002
481 TYPE 2 DIABETES MELLITUS 6 0.0002
482 ANGER 6 0.0002
483 CHROMATURIA 4 0.0002
484 HEART RATE IRREGULAR 4 0.0002
485 COLECTOMY 1 0.0002
486 ACUTE KIDNEY INJURY 27 0.0002
487 IMPAIRED DRIVING ABILITY 2 0.0002
488 INTENTIONAL DOSE OMISSION 5 0.0002
489 SCAR 3 0.0002
490 MICTURITION URGENCY 2 0.0002
491 GASTRIC DISORDER 6 0.0002
492 NEPHROLITHIASIS 8 0.0002
493 DELIRIUM 6 0.0002
494 MADAROSIS 2 0.0002
495 UNEVALUABLE EVENT 13 0.0002
496 CAESAREAN SECTION 2 0.0002
497 SPLENOMEGALY 2 0.0002
498 SEXUAL DYSFUNCTION 2 0.0002
499 COLD SWEAT 3 0.0002
500 BLOOD PRESSURE INCREASED 26 0.0002
501 CATARACT OPERATION 1 0.0002
502 DIZZINESS 84 0.0002
503 GALLBLADDER DISORDER 3 0.0002
504 CARDIAC PACEMAKER INSERTION 1 0.0002
505 GOUT 3 0.0002
506 ENDOPHTHALMITIS 1 0.0002
507 BLOOD GLUCOSE DECREASED 8 0.0002
508 GASTROENTERITIS VIRAL 3 0.0002
509 INFUSION RELATED REACTION 11 0.0002
510 HEPATIC FAILURE 5 0.0002
511 RESTLESS LEGS SYNDROME 3 0.0002
512 DERMATITIS ACNEIFORM 1 0.0002
513 RESTLESSNESS 6 0.0002
514 RESPIRATORY DEPRESSION 2 0.0002
515 HYPERHIDROSIS 21 0.0002
516 LIVER INJURY 4 0.0002
517 CARDIOMEGALY 2 0.0002
518 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
519 CONJUNCTIVITIS 3 0.0002
520 ABDOMINAL DISCOMFORT 27 0.0002
521 MENTAL DISORDER 7 0.0002
522 BACTERIAL INFECTION 3 0.0002
523 HAIR COLOUR CHANGES 2 0.0002
524 SWOLLEN TONGUE 5 0.0002
525 INJECTION SITE DISCOLOURATION 2 0.0002
526 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
527 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
528 HOT FLUSH 12 0.0002
529 BLEPHAROSPASM 1 0.0002
530 BLOOD URINE PRESENT 3 0.0002
531 DEHYDRATION 21 0.0002
532 FEELING JITTERY 3 0.0002
533 MOOD SWINGS 5 0.0002
534 CHEST DISCOMFORT 16 0.0002
535 SEROTONIN SYNDROME 3 0.0002
536 SLEEP DISORDER 11 0.0002
537 ROTATOR CUFF SYNDROME 2 0.0002
538 MOVEMENT DISORDER 5 0.0002
539 CARDIAC FLUTTER 1 0.0002
540 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
541 APPLICATION SITE VESICLES 1 0.0002
542 DIPLOPIA 4 0.0002
543 HEPATITIS ACUTE 1 0.0002
544 PLATELET COUNT INCREASED 2 0.0002
545 BEDRIDDEN 2 0.0002
546 PULMONARY CONGESTION 2 0.0002
547 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
548 ABNORMAL BEHAVIOUR 6 0.0002
549 CORONAVIRUS INFECTION 1 0.0002
550 UNDERDOSE 11 0.0002
551 EXPIRED PRODUCT ADMINISTERED 5 0.0002
552 VIRAL INFECTION 5 0.0002
553 LIP SWELLING 5 0.0001
554 IRRITABILITY 9 0.0001
555 GAIT INABILITY 5 0.0001
556 HAIR TEXTURE ABNORMAL 2 0.0001
557 PERIPHERAL SWELLING 23 0.0001
558 MALIGNANT MELANOMA 2 0.0001
559 PRODUCT PHYSICAL ISSUE 3 0.0001
560 INTENTIONAL SELF-INJURY 3 0.0001
561 BRONCHIECTASIS 1 0.0001
562 DISTURBANCE IN ATTENTION 8 0.0001
563 FEEDING DISORDER 3 0.0001
564 LIMB INJURY 4 0.0001
565 AKATHISIA 2 0.0001
566 EYE MOVEMENT DISORDER 1 0.0001
567 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
568 PERIPHERAL COLDNESS 2 0.0001
569 ABNORMAL DREAMS 4 0.0001
570 DROOLING 1 0.0001
571 TOOTH LOSS 3 0.0001
572 DIVERTICULITIS 4 0.0001
573 RHABDOMYOLYSIS 6 0.0001
574 FATIGUE 112 0.0001
575 FORMICATION 1 0.0001
576 BLOOD GLUCOSE INCREASED 27 0.0001
577 EXTRASYSTOLES 1 0.0001
578 HEART RATE DECREASED 5 0.0001
579 HALLUCINATION, VISUAL 3 0.0001
580 HAND FRACTURE 1 0.0001
581 DEPRESSION 32 0.0001
582 CHEST PAIN 26 0.0001
583 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
584 POOR QUALITY SLEEP 3 0.0001
585 BALANCE DISORDER 12 0.0001
586 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
587 MEMORY IMPAIRMENT 19 0.0001
588 NAUSEA 109 0.0001
589 CRYING 5 0.0001
590 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
591 DYSSTASIA 4 0.0001
592 DIARRHOEA 88 0.0001
593 ABDOMINAL PAIN UPPER 28 0.0001
594 BLINDNESS TRANSIENT 1 0.0001
595 TACHYCARDIA 12 0.0001
596 ARTHROPOD BITE 1 0.0001
597 TOOTH DISORDER 3 0.0001
598 PULMONARY MASS 2 0.0001
599 IMMUNODEFICIENCY 2 0.0001
600 ABDOMINAL DISTENSION 14 0.0001
601 ORAL PAIN 3 0.0001
602 NERVOUSNESS 7 0.0001
603 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
604 RESPIRATORY DISORDER 4 0.0001
605 CONSTIPATION 29 0.0001
606 PYREXIA 46 0.0001
607 DYSARTHRIA 5 0.0001
608 INTESTINAL OBSTRUCTION 5 0.0001
609 APHASIA 4 0.0001
610 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
611 STOMATITIS 8 0.0001
612 COLITIS 5 0.0001
613 OSTEOPENIA 2 0.0001
614 SUICIDAL IDEATION 12 0.0001
615 BOWEL MOVEMENT IRREGULARITY 1 0.0001
616 DISSOCIATION 1 0.0001
617 PNEUMONIA 42 0.0001
618 FOOD ALLERGY 1 0.0001
619 CONCUSSION 1 0.0001
620 URINARY TRACT INFECTION 22 0.0001
621 DELUSION 2 0.0001
622 HAEMORRHAGIC STROKE 1 0.0001
623 RENAL FAILURE 17 0.0001
624 MALAISE 56 0.0001
625 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
626 INCORRECT DOSE ADMINISTERED 29 0.0001
627 PRODUCT USE COMPLAINT 2 0.0001
628 ARRHYTHMIA 6 0.0001
629 TREMOR 21 0.0001
630 GINGIVAL PAIN 1 0.0001
631 ATRIAL FLUTTER 1 0.0001
632 HYPOTHYROIDISM 4 0.0001
633 NECK PAIN 7 0.0001
634 BLOOD DISORDER 1 0.0001
635 ABORTION SPONTANEOUS 5 0.0001
636 CONTUSION 12 0.0001
637 NIGHT SWEATS 4 0.0001
638 FRUSTRATION TOLERANCE DECREASED 1 0.0001
639 CONFUSIONAL STATE 20 0.0001
640 MUSCLE TIGHTNESS 2 0.0001
641 PRESYNCOPE 3 0.0001
642 DYSKINESIA 5 0.0001
643 HEADACHE 77 0.0001
644 LUNG DISORDER 6 0.0001
645 ABNORMAL FAECES 1 0.0001
646 HICCUPS 1 0.0001
647 OSTEOPOROSIS 5 0.0001
648 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
649 PARAESTHESIA 19 0.0001
650 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
651 WITHDRAWAL SYNDROME 5 0.0001
652 CELLULITIS 6 0.0001
653 DRUG USE DISORDER 1 0.0001
654 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
655 ERYTHEMA 24 0.0001
656 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
657 INFLAMMATION 6 0.0001
658 PRODUCT DOSE OMISSION ISSUE 34 0.0001
659 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
660 DRUG DOSE OMISSION 19 0.0001
661 VERTIGO 7 0.0001
662 WEIGHT DECREASED 32 0.0001
663 FEELING HOT 7 0.0001
664 FALL 38 0.0001
665 ANHEDONIA 3 0.0001
666 BLOOD CALCIUM INCREASED 1 0.0001
667 GROIN PAIN 1 0.0001
668 INJURY 8 0.0001
669 GRIP STRENGTH DECREASED 1 0.0001
670 HYPOAESTHESIA 17 0.0001
671 LYMPHOCYTE COUNT DECREASED 2 0.0001
672 LYMPHADENOPATHY 4 0.0001
673 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
674 ALOPECIA 22 0.0001
675 DECREASED APPETITE 26 0.0001
676 ASTHENIA 42 0.0001
677 WEIGHT INCREASED 25 0.0001
678 FEAR 3 0.0001
679 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
680 HEART RATE INCREASED 11 0.0001
681 PALPITATIONS 13 0.0001
682 LEUKOCYTOSIS 2 0.0001
683 TOOTHACHE 2 0.0001
684 OSTEOMYELITIS 2 0.0001
685 PELVIC PAIN 2 0.0001
686 SYNCOPE 11 0.0001
687 VISION BLURRED 15 0.0001
688 PAIN 67 0.0001
689 CARDIAC ARREST 9 0.0001
690 TINNITUS 5 0.0001
691 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
692 DRUG ABUSE 9 0.0001
693 FEELING COLD 3 0.0001
694 BACK PAIN 25 0.0001
695 HAEMOPTYSIS 3 0.0001
696 HEPATIC STEATOSIS 2 0.0001
697 WOUND 3 0.0001
698 RENAL DISORDER 5 0.0001
699 EPISTAXIS 8 0.0001
700 OXYGEN SATURATION DECREASED 6 0.0001
701 FLANK PAIN 1 0.0001
702 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
703 ABORTION INDUCED 1 0.0001
704 ASTHMA 12 0.0001
705 FLATULENCE 6 0.0001
706 OCULAR HYPERAEMIA 5 0.0001
707 HERPES ZOSTER 6 0.0001
708 PULMONARY FIBROSIS 2 0.0001
709 PRODUCT SUBSTITUTION ISSUE 6 0.0001
710 ACUTE RESPIRATORY FAILURE 2 0.0001
711 AFFECT LABILITY 1 0.0001
712 ERUCTATION 2 0.0001
713 ABDOMINAL PAIN 24 0.0001
714 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
715 AUTOIMMUNE DISORDER 1 0.0001
716 HAEMORRHOIDS 2 0.0001
717 CHOKING 2 0.0001
718 ORAL HERPES 2 0.0001
719 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
720 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
721 HEPATOMEGALY 1 0.0001
722 ARTHRITIS 8 0.0001
723 PSYCHOTIC DISORDER 3 0.0001
724 RENAL INJURY 3 0.0001
725 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
726 CATARACT 6 0.0001
727 ADVERSE DRUG REACTION 9 0.0001
728 DRY EYE 5 0.0001
729 SPINAL FRACTURE 2 0.0001
730 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
731 DYSPNOEA 56 0.0001
732 EYELID PTOSIS 1 0.0001
733 DRUG LEVEL DECREASED 1 0.0001
734 INJURY ASSOCIATED WITH DEVICE 2 0.0001
735 SKIN BURNING SENSATION 7 0.0001
736 EAR DISCOMFORT 1 0.0001
737 THERAPY CESSATION 5 0.0001
738 EMOTIONAL DISORDER 3 0.0001
739 SWELLING 9 0.0001
740 COMPLETED SUICIDE 8 0.0001
741 MUSCULOSKELETAL PAIN 5 0.0001
742 FOLLICULITIS 1 0.0001
743 MOUTH ULCERATION 2 0.0001
744 DYSPHAGIA 9 0.0001
745 HYPERTENSION 20 0.0001
746 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
747 EATING DISORDER 2 0.0001
748 RETCHING 2 0.0001
749 BREAST PAIN 1 0.0001
750 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
751 JOINT INJURY 2 0.0001
752 LIVER FUNCTION TEST INCREASED 2 0.0001
753 HYPOACUSIS 4 0.0001
754 MUSCLE SPASMS 17 0.0001
755 PRURITUS GENERALISED 2 0.0001
756 SWELLING FACE 6 0.0001
757 BACK INJURY 1 0.0001
758 PRODUCT DISPENSING ERROR 2 0.0001
759 HYPERSENSITIVITY 17 0.0001
760 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
761 CHOLELITHIASIS 3 0.0001
762 ASPIRATION 1 0.0001
763 BLOOD GLUCOSE FLUCTUATION 1 0.0001
764 FOOT DEFORMITY 1 0.0001
765 HEPATOTOXICITY 2 0.0001
766 INFECTION 13 0.0001
767 URTICARIA 15 0.0001
768 RASH 39 0.0001
769 GASTROINTESTINAL DISORDER 8 0.0001
770 PANCREATITIS ACUTE 2 0.0001
771 BLOOD CALCIUM DECREASED 1 0.0001
772 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
773 GAIT DISTURBANCE 17 0.0001
774 CONDITION AGGRAVATED 27 0.0001
775 EYE PAIN 5 0.0001
776 DERMATITIS CONTACT 1 0.0001
777 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
778 CHOLECYSTECTOMY 1 0.0001
779 MUSCLE TWITCHING 2 0.0001
780 HYPOKALAEMIA 4 0.0001
781 PERICARDIAL EFFUSION 2 0.0001
782 PRURITUS 33 0.0001
783 RASH MACULAR 3 0.0001
784 CARDIAC DISORDER 8 0.0001
785 PRODUCT USE ISSUE 16 0.0001
786 PAIN IN EXTREMITY 25 0.0001
787 PLATELET COUNT DECREASED 9 0.0001
788 ATAXIA 1 0.0001
789 PRODUCT PRESCRIBING ERROR 2 0.0001
790 CEREBRAL HAEMORRHAGE 3 0.0001
791 ACCIDENT 1 0.0001
792 MOBILITY DECREASED 6 0.0001
793 BLOOD PRESSURE FLUCTUATION 2 0.0001
794 EMOTIONAL DISTRESS 10 0.0001
795 DRUG EFFECT INCOMPLETE 3 0.0001
796 BURSITIS 1 0.0001
797 DRY SKIN 11 0.0001
798 ATRIAL FIBRILLATION 8 0.0001
799 DISCOMFORT 5 0.0001
800 AGITATION 6 0.0001
801 ENCEPHALOPATHY 2 0.0001
802 DYSPEPSIA 8 0.0001
803 ABASIA 2 0.0001
804 GENERALISED OEDEMA 1 0.0001
805 CYST 1 0.0001
806 EXPOSURE DURING PREGNANCY 5 0.0001
807 HEPATIC FUNCTION ABNORMAL 3 0.0001
808 DERMATITIS ALLERGIC 1 0.0001
809 BRAIN OEDEMA 1 0.0001
810 ABDOMINAL PAIN LOWER 2 0.0001
811 HYPOPHAGIA 2 0.0001
812 HAEMOGLOBIN DECREASED 8 0.0001
813 ERECTILE DYSFUNCTION 2 0.0001
814 HIATUS HERNIA 1 0.0001
815 EXPOSURE VIA SKIN CONTACT 2 0.0001
816 PLASMA CELL MYELOMA 3 0.0001
817 AMNESIA 5 0.0001
818 DEAFNESS 2 0.0001
819 ECZEMA 4 0.0001
820 JOINT STIFFNESS 2 0.0001
821 GASTRITIS 2 0.0001
822 ANKYLOSING SPONDYLITIS 1 0.0001
823 DISORIENTATION 3 0.0001
824 INJECTION SITE BRUISING 6 0.0001
825 EYE HAEMORRHAGE 1 0.0001
826 JAUNDICE 2 0.0001
827 PALLOR 2 0.0001
828 HEPATIC ENZYME INCREASED 5 0.0001
829 VISUAL IMPAIRMENT 9 0.0001
830 ANAPHYLACTIC REACTION 4 0.0001
831 ARTHROPATHY 4 0.0001
832 SEPSIS 8 0.0001
833 COORDINATION ABNORMAL 1 0.0001
834 DEMENTIA 2 0.0001
835 CARPAL TUNNEL SYNDROME 1 0.0001
836 BURNING SENSATION 5 0.0001
837 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
838 BLINDNESS UNILATERAL 1 0.0001
839 RENAL FAILURE ACUTE 3 0.0001
840 PAIN IN JAW 2 0.0001
841 MUSCULAR WEAKNESS 8 0.0001
842 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
843 BRONCHOSPASM 1 0.0001
844 THERAPY INTERRUPTED 5 0.0001
845 RED BLOOD CELL COUNT DECREASED 2 0.0001
846 RECTAL HAEMORRHAGE 3 0.0001
847 HYPOTENSION 14 0.0001
848 ARTHRALGIA 29 0.0001
849 CARDIOGENIC SHOCK 1 0.0001
850 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
851 APATHY 1 0.0001
852 PRODUCT STORAGE ERROR 6 0.0001
853 MUSCULOSKELETAL STIFFNESS 6 0.0001
854 BONE PAIN 4 0.0001
855 ANGIOEDEMA 3 0.0001
856 LABORATORY TEST ABNORMAL 2 0.0001
857 LIVER DISORDER 3 0.0001
858 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
859 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
860 COLITIS ULCERATIVE 3 0.0001
861 PULMONARY OEDEMA 3 0.0001
862 HAEMORRHAGE 7 0.0001
863 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
864 BLOOD COUNT ABNORMAL 1 0.0001
865 PLEURAL EFFUSION 4 0.0001
866 DRUG INEFFECTIVE 86 0.0001
867 INJECTION SITE RASH 2 0.0001
868 DRUG ADMINISTRATION ERROR 2 0.0001
869 CEREBROVASCULAR ACCIDENT 11 0.0001
870 MYALGIA 11 0.0001
871 LIMB DISCOMFORT 2 0.0001
872 BONE DENSITY DECREASED 2 0.0001
873 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
874 NEUROPATHY PERIPHERAL 6 0.0001
875 RASH ERYTHEMATOUS 3 0.0001
876 HIP FRACTURE 2 0.0001
877 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
878 BACK DISORDER 1 0.0001
879 EYE DISORDER 2 0.0001
880 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
881 VISUAL ACUITY REDUCED 2 0.0001
882 AGGRESSION 3 0.0001
883 URINARY RETENTION 2 0.0001
884 SKIN EXFOLIATION 5 0.0001
885 CANDIDA INFECTION 1 0.0001
886 HEMIPARESIS 1 0.0001
887 FLUSHING 6 0.0001
888 FLUID RETENTION 3 0.0001
889 CIRCULATORY COLLAPSE 1 0.0001
890 DEVICE USE ERROR 2 0.0001
891 HYPERKALAEMIA 2 0.0001
892 DRUG WITHDRAWAL SYNDROME 5 0.0001
893 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
894 DRUG ERUPTION 1 0.0001
895 DEVICE ISSUE 5 0.0001
896 RASH PRURITIC 3 0.0001
897 HYPERGLYCAEMIA 2 0.0001
898 RESPIRATORY FAILURE 4 0.0001
899 TREATMENT NONCOMPLIANCE 3 0.0001
900 OFF LABEL USE 48 0.0001
901 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
902 ADVERSE EVENT 5 0.0001
903 BLOOD GLUCOSE ABNORMAL 1 0.0001
904 MEDICATION ERROR 3 0.0001
905 EYE SWELLING 2 0.0001
906 DYSPNOEA EXERTIONAL 2 0.0001
907 BLOOD SODIUM DECREASED 1 0.0001
908 GASTRIC ULCER 1 0.0001
909 DIABETES MELLITUS 4 0.0001
910 INJECTION SITE SWELLING 4 0.0001
911 DRUG PRESCRIBING ERROR 1 0.0001
912 GLAUCOMA 1 0.0001
913 HERNIA 1 0.0001
914 SURGERY 3 0.0001
915 HAEMATOCRIT DECREASED 1 0.0001
916 CARDIAC FAILURE CONGESTIVE 4 0.0000
917 DRUG DEPENDENCE 8 0.0000
918 THROMBOSIS 4 0.0000
919 FULL BLOOD COUNT DECREASED 1 0.0000
920 PSORIATIC ARTHROPATHY 2 0.0000
921 BODY TEMPERATURE INCREASED 1 0.0000
922 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
923 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
924 ROAD TRAFFIC ACCIDENT 2 0.0000
925 RENAL IMPAIRMENT 4 0.0000
926 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
927 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
928 PRODUCT DOSE OMISSION 3 0.0000
929 MYOCARDIAL INFARCTION 8 0.0000
930 THROMBOCYTOPENIA 5 0.0000
931 NO ADVERSE EVENT 8 0.0000
932 APPLICATION SITE PRURITUS 1 0.0000
933 SKIN IRRITATION 2 0.0000
934 BLOOD CHOLESTEROL INCREASED 2 0.0000
935 COGNITIVE DISORDER 2 0.0000
936 DIABETIC KETOACIDOSIS 1 0.0000
937 JOINT SWELLING 5 0.0000
938 FIBROMYALGIA 1 0.0000
939 CEREBRAL INFARCTION 1 0.0000
940 INJECTION SITE ERYTHEMA 5 0.0000
941 GASTRIC CANCER 1 0.0000
942 HAEMATEMESIS 1 0.0000
943 HOSPITALISATION 6 0.0000
944 PSORIASIS 5 0.0000
945 APPLICATION SITE ERYTHEMA 1 0.0000
946 PANCREATITIS 2 0.0000
947 DEPRESSED MOOD 2 0.0000
948 DRUG EFFECT DECREASED 2 0.0000
949 FREQUENT BOWEL MOVEMENTS 1 0.0000
950 OEDEMA 2 0.0000
951 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
952 RHEUMATOID ARTHRITIS 4 0.0000
953 ASCITES 1 0.0000
954 ACUTE MYOCARDIAL INFARCTION 1 0.0000
955 THERAPEUTIC RESPONSE DECREASED 2 0.0000
956 ILL-DEFINED DISORDER 2 0.0000
957 GYNAECOMASTIA 1 0.0000
958 PULMONARY EMBOLISM 3 0.0000
959 DEEP VEIN THROMBOSIS 2 0.0000
960 FUNGAL INFECTION 1 0.0000
961 EYE PRURITUS 1 0.0000
962 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
963 HAEMATURIA 1 0.0000
964 ACNE 2 0.0000
965 ANAEMIA 5 0.0000
966 DISEASE PROGRESSION 3 0.0000
967 INJECTION SITE HAEMORRHAGE 2 0.0000
968 CARDIAC FAILURE 2 0.0000
969 DEVICE BREAKAGE 1 0.0000
970 OEDEMA PERIPHERAL 3 0.0000
971 BLINDNESS 1 0.0000
972 DEATH 20 0.0000
973 DEVICE DISLOCATION 1 0.0000
974 PRODUCT QUALITY ISSUE 3 0.0000
975 COMA 1 0.0000
976 DERMATITIS ATOPIC 1 0.0000
977 BRADYCARDIA 1 0.0000
978 DEPENDENCE 1 0.0000
979 HAEMATOCHEZIA 1 0.0000
980 CONVULSION 1 0.0000
981 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
982 INJECTION SITE PAIN 5 0.0000
983 DEVICE DIFFICULT TO USE 1 0.0000
984 FEBRILE NEUTROPENIA 1 0.0000
985 DEVICE MALFUNCTION 1 0.0000
986 DRUG DOSE OMISSION BY DEVICE 1 0.0000
987 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
988 BREAST CANCER 1 0.0000
989 DRUG INTOLERANCE 1 0.0000